Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 2
2019 2
2020 4
2021 4
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis.
Farjallah A, Chiarelli LR, Forbak M, Degiacomi G, Danel M, Goncalves F, Carayon C, Seguin C, Fumagalli M, Záhorszká M, Vega E, Abid S, Grzegorzewicz A, Jackson M, Peixoto A, Korduláková J, Pasca MR, Lherbet C, Chassaing S. Farjallah A, et al. Among authors: abid s. ACS Infect Dis. 2021 Mar 12;7(3):552-565. doi: 10.1021/acsinfecdis.0c00325. Epub 2021 Feb 22. ACS Infect Dis. 2021. PMID: 33617235 Free PMC article.
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram.
Ghazouani L, Khdhiri E, Elmufti A, Zarei A, Feriani A, Baaziz I, Hajji R, Abid M, Ammar H, Abid S, Allouche N, Mnafgui K, Ramazani A, Tlili N. Ghazouani L, et al. Among authors: abid s. Clin Exp Pharmacol Physiol. 2022 Sep;49(9):1010-1026. doi: 10.1111/1440-1681.13690. Epub 2022 Jul 24. Clin Exp Pharmacol Physiol. 2022. PMID: 35717592
Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke.
Mnafgui K, Khdhiri E, Ghazouani L, Ncir M, Zaafouri Z, Allouche N, Elfeki A, Ammar H, Abid S, Hajji R. Mnafgui K, et al. Among authors: abid s. Arch Physiol Biochem. 2021 Dec;127(6):527-540. doi: 10.1080/13813455.2019.1657900. Epub 2019 Aug 30. Arch Physiol Biochem. 2021. PMID: 31469295
Potential effect of new (E)-4-hydroxy -N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies.
Mnafgui K, Khdhiri E, Hajji R, Feriani A, Ivan da Silva F, Laíres da Silva Santos A, Tlili A, Mlayeh S, Bouzidi M, Ammar H, Abid S. Mnafgui K, et al. Among authors: abid s. Clin Exp Pharmacol Physiol. 2021 Jan;48(1):107-120. doi: 10.1111/1440-1681.13397. Epub 2020 Sep 28. Clin Exp Pharmacol Physiol. 2021. PMID: 32780517
Cardiopreventive capacity of a novel (E)-N'-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters.
Khdhiri E, Mnafgui K, Ncir M, Feriani A, Ghazouani L, Hajji R, Jallouli D, Abid M, Jamoussi K, Allouche N, Ammar H, Abid S. Khdhiri E, et al. Among authors: abid s. J Biochem Mol Toxicol. 2021 Jun;35(6):e22747. doi: 10.1002/jbt.22747. Epub 2021 Feb 23. J Biochem Mol Toxicol. 2021. PMID: 33624406
(E)-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide protecting rat heart tissues from isoproterenol toxicity: Evidence from in vitro and in vivo tests.
Khdhiri E, Mnafgui K, Ghazouani L, Feriani A, Hajji R, Bouzanna W, Allouche N, Bazureau JP, Ammar H, Abid S. Khdhiri E, et al. Among authors: abid s. Eur J Pharmacol. 2020 Aug 15;881:173137. doi: 10.1016/j.ejphar.2020.173137. Epub 2020 May 4. Eur J Pharmacol. 2020. PMID: 32380016 Free article.
Design and Synthesis of Novel N-Benzylidene Derivatives of 3-Amino-4-imino-3,5-dihydro-4H-chromeno[2,3-d]pyrimidine under Microwave, In Silico ADME Predictions, In Vitro Antitumoral Activities and In Vivo Toxicity.
Karoui S, Dhiabi M, Fakhfakh M, Abid S, Limanton E, Le Guével R, Charlier TD, Mainguy A, Mignen O, Paquin L, Ammar H, Bazureau JP. Karoui S, et al. Among authors: abid s. Pharmaceuticals (Basel). 2024 Apr 2;17(4):458. doi: 10.3390/ph17040458. Pharmaceuticals (Basel). 2024. PMID: 38675418 Free PMC article.
14 results